Cholic Acid
Systematic Name
3α,7α,12α-Trihydroxy-5β-cholan-24-oic acid
Cholic acid is indicated for the treatment of bile acid synthesis disorders due to single enzyme defects (SEDs) and it is also indicated for adjunctive treatment of peroxisomal disorders (PDs) including Zellweger spectrum disorders in patients who exhibit manifestations of liver disease.
Therapeutic Category
Bile acid synthesis disorders & Peroxisomal Disorders
CAS No
81-25-4
Suitable Formulations
Solid
Approvals
US DMF*